Search In this Thesis
   Search In this Thesis  
العنوان
Immunological study before and after thyroidectomy in non-malignant thyroid enlargements /
المؤلف
Soliman, Mosaad.
هيئة الاعداد
باحث / Mosaad Soliman
مشرف / Atef Abd El-Latif
مشرف / El-Sayed Sallam
مشرف / Farha El-Shennawy
مشرف / Ramadan El-Laithy
مشرف / Leslie Degroot
الموضوع
Thyroidectomy-- Physiological aspects.
تاريخ النشر
1994.
عدد الصفحات
161 p. :
اللغة
الإنجليزية
الدرجة
الدكتوراه
التخصص
الطب
تاريخ الإجازة
1/1/1994
مكان الإجازة
جامعة المنصورة - كلية الطب - Department of General Surgery
الفهرس
Only 14 pages are availabe for public view

from 178

from 178

Abstract

The effect of treatment on thyroid antibody production and T cell reactivity to thyroid antigens was studied in 19 patients with AITD before and after thyroidectomy, 19 patients with GD before and after RAI therapy, 9 patients maintained euthyroid on antithyroid drugs (ATD) and 12 patients with CNG before and after lobectomy or partial thyroidectomy. Twenty subjects matched for age and sex without known thyroid disease served as controls. In AITD patients and patients with CNG, the responses of PBMC and TSHR-specific T cell lines to recombinant human TSHR extracellular domain (rec h TSHR-BCD), thyroglobulin (Tg) and TSHR peptides were examined at the day of surgery or RAI therapy (day 0) and also 6-8 weeks and 3-6 months thereafter. Reactivity to TSHR peptides before surgery was heterogeneous and spanned the entire BCD. 6-8 weeks after subtotal thyroidectomy, the number of patients PBMC responding to any peptide and the average number of recognized peptides decreased. a further decrease in the T cell reactivity to TSHR peptides was observed 3-6 months after surgery. Responses of PBMC from Graves’ patients prior to RAI therapy were less than in the pre-surgical group. At 6-8 weeks after RAJ therapy, the number of patients responding to any peptide and the average number of recognized peptides increased. 3-6 months after RAI, T cell responses to TSHR peptides were less than at 6-8 weeks after RAI therapy but still higher than the values at day O. Responses of PBMC from patients with GD, maintained euthyroid on ATD, were lower than those before surgery or RAI therapy. In CNG patients, T cell reactivity was restricted to rec h TSHR-BCD and one peptide. T cell responses to thyroid . antigens was lost after thyroidectomy. Reactivity of T celllines in different groups reflected a pattern similar to PBMC following treatment. TSHR antibody (TSAb) and microsomal antibody (McAb) levels decreased after surgery but increased